Share Price and Basic Stock Data
Last Updated: November 28, 2025, 11:15 am
| PEG Ratio | -0.43 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Garodia Chemical Ltd operates in the trading and distribution industry, with its stock currently priced at ₹7.75 and a market capitalization of ₹5.58 Cr. The company has reported zero sales across multiple quarters, including Jun 2022 to Mar 2024. This stagnation in revenue generation raises significant concerns about its operational viability. The reported expenses have fluctuated slightly, with a peak of ₹0.05 Cr in Jun 2023, reflecting ongoing operational costs despite the absence of sales. The lack of revenue since at least Mar 2014 indicates a consistent struggle for business growth. The company’s performance in terms of sales is notably below industry norms, which typically see consistent revenue streams. This persistent lack of sales raises questions about the management’s ability to adapt to market conditions or innovate product offerings, which is critical for survival in a competitive trading environment.
Profitability and Efficiency Metrics
Garodia Chemical Ltd has reported negative profitability metrics, with a net profit of -₹0.25 Cr and a P/E ratio of 1.47, which is atypical for companies in the trading sector. The operating profit margin (OPM) has not been reported, but the operating profit has consistently been negative, peaking at -₹0.05 Cr in Jun 2023. Despite these challenges, the company has recorded an impressive return on capital employed (ROCE) of 323%, indicating that any capital deployed has been utilized effectively, albeit within a context of negative operational performance. The negative net profit margins and losses over multiple fiscal years highlight significant operational inefficiencies. The absence of interest expenses further complicates the financial picture, as it suggests low leverage, yet the company fails to convert its operational capacity into profitable outcomes.
Balance Sheet Strength and Financial Ratios
Garodia Chemical Ltd’s balance sheet reflects a complicated financial position, with no reported reserves or borrowings. The company’s price-to-book value (P/BV) stands at -2.04x, indicating that its liabilities exceed its assets, which poses a risk to financial stability. The current ratio is reported at 4.36, suggesting that the company can cover its short-term liabilities multiple times over, which is a significant strength. However, the overall financial health is undermined by negative book value per share at -₹6.52. The return on equity (ROE) remains unreported, yet the high ROCE suggests effective capital use in scenarios where revenue generation is absent. As a result, while liquidity appears strong, the overall solvency and profitability metrics present a concerning picture for potential investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Garodia Chemical Ltd indicates a stable ownership structure, with promoters holding 51.79% of the company. Government holdings are at 10.42%, while public shareholders account for 37.79%, with a total of 7,647 shareholders as of Jun 2023. The consistent promoter stake suggests a commitment to the company, which can instill confidence among investors. However, the absence of foreign institutional investments (FIIs) and domestic institutional investments (DIIs) may point to a lack of external confidence in the company’s future prospects. The stability in the shareholder base is a positive aspect; however, the lack of growth and profitability could deter new investments, thereby limiting the company’s ability to attract further capital needed for operational improvements.
Outlook, Risks, and Final Insight
Garodia Chemical Ltd faces significant risks, primarily stemming from its inability to generate sales and maintain profitability. The ongoing negative net profits and lack of operational revenues present substantial challenges for future growth. However, the company’s high ROCE indicates potential for efficiency in capital utilization, which could be a strength if revenue generation improves. The strong current ratio offers some assurance regarding liquidity, suggesting that while the company is presently in a precarious position, it has the means to manage short-term obligations. Moving forward, the company must address its operational inefficiencies and explore avenues for revenue generation to enhance its financial health. Should Garodia Chemical Ltd manage to pivot its strategy effectively, it may regain investor confidence and stabilize its financial standing.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Garodia Chemical Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minal Industries Ltd | 64.8 Cr. | 3.38 | 5.59/3.20 | 43.2 | 2.78 | 0.00 % | 5.97 % | 2.83 % | 2.00 |
| Modella Woollens Ltd | 6.28 Cr. | 69.0 | 74.8/52.5 | 4.95 | 0.00 % | % | % | 10.0 | |
| MRC Agrotech Ltd | 104 Cr. | 50.6 | 54.5/10.2 | 115 | 15.1 | 0.00 % | 5.89 % | 4.46 % | 10.0 |
| MRP Agro Ltd | 107 Cr. | 96.0 | 174/84.4 | 15.1 | 30.6 | 0.00 % | 39.2 % | 30.3 % | 10.0 |
| Muller and Phipps (India) Ltd | 15.0 Cr. | 240 | 548/208 | 188 | 22.9 | 0.00 % | % | % | 10.0 |
| Industry Average | 10,638.20 Cr | 163.27 | 90.53 | 122.49 | 0.40% | 15.57% | 8.99% | 7.71 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.01 | 0.01 | 0.01 | 0.02 | 0.05 | 0.01 | 0.04 | 0.03 | 0.01 | 0.02 | 0.05 | 0.12 | 0.06 |
| Operating Profit | -0.01 | -0.01 | -0.01 | -0.02 | -0.05 | -0.01 | -0.04 | -0.03 | -0.01 | -0.02 | -0.05 | -0.12 | -0.06 |
| OPM % | |||||||||||||
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.01 | -0.01 | -0.01 | -0.02 | -0.05 | -0.01 | -0.04 | -0.03 | -0.01 | -0.02 | -0.05 | -0.12 | -0.06 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -0.01 | -0.01 | -0.01 | -0.02 | -0.05 | -0.01 | -0.04 | -0.03 | -0.01 | -0.02 | -0.05 | -0.12 | -0.06 |
| EPS in Rs | -0.01 | -0.01 | -0.01 | -0.03 | -0.07 | -0.01 | -0.06 | -0.04 | -0.01 | -0.03 | -0.07 | -0.17 | -0.08 |
Last Updated: August 19, 2025, 2:50 pm
Below is a detailed analysis of the quarterly data for Garodia Chemical Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Expenses, as of Jun 2025, the value is 0.06 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.12 Cr. (Mar 2025) to 0.06 Cr., marking a decrease of 0.06 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.06 Cr.. The value appears strong and on an upward trend. It has increased from -0.12 Cr. (Mar 2025) to -0.06 Cr., marking an increase of 0.06 Cr..
- For OPM %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.06 Cr.. The value appears strong and on an upward trend. It has increased from -0.12 Cr. (Mar 2025) to -0.06 Cr., marking an increase of 0.06 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Net Profit, as of Jun 2025, the value is -0.06 Cr.. The value appears strong and on an upward trend. It has increased from -0.12 Cr. (Mar 2025) to -0.06 Cr., marking an increase of 0.06 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.08. The value appears strong and on an upward trend. It has increased from -0.17 (Mar 2025) to -0.08, marking an increase of 0.09.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 3:17 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.06 | 0.07 | 0.21 | 0.11 | 0.13 | 0.20 | 0.26 | 0.18 | 0.09 | 0.06 | 0.13 | 0.21 | 0.25 |
| Operating Profit | -0.06 | -0.07 | -0.21 | -0.11 | -0.13 | -0.20 | -0.26 | -0.18 | -0.10 | -0.06 | -0.13 | -0.21 | -0.25 |
| OPM % | |||||||||||||
| Other Income | 0.00 | -1.67 | 6.14 | 0.00 | 3.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.12 | 0.11 | 0.11 | 0.11 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.18 | -1.85 | 5.82 | -0.22 | 3.32 | -0.20 | -0.68 | -0.18 | -0.10 | -0.06 | -0.13 | -0.21 | -0.25 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Net Profit | -0.18 | -1.85 | 5.81 | -0.22 | 3.32 | -0.20 | -0.68 | -0.18 | -0.10 | -0.06 | -0.13 | -0.21 | -0.25 |
| EPS in Rs | -0.25 | -2.57 | 8.07 | -0.31 | 4.61 | -0.28 | -0.94 | -0.25 | -0.14 | -0.08 | -0.18 | -0.29 | -0.35 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -927.78% | 414.05% | -103.79% | 1609.09% | -106.02% | -240.00% | 73.53% | 44.44% | 40.00% | -116.67% | -61.54% |
| Change in YoY Net Profit Growth (%) | 0.00% | 1341.83% | -517.84% | 1712.88% | -1715.12% | -133.98% | 313.53% | -29.08% | -4.44% | -156.67% | 55.13% |
Garodia Chemical Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 11% |
| 3 Years: | % |
| TTM: | -178% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 3% |
| 3 Years: | 3% |
| 1 Year: | 3% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 3:31 pm
No data available for the Balance Sheet data table.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | |||||||||||
| Inventory Days | 0.00 | |||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 0.00 | |||||||||||
| Working Capital Days | -1,825.00 | |||||||||||
| ROCE % | -23.91% | 40.79% | -53.33% | -346.67% | -900.00% | -323.08% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.29 | -0.18 | -0.08 | -0.14 | -0.24 |
| Diluted EPS (Rs.) | -0.29 | -0.18 | -0.08 | -0.14 | -0.24 |
| Cash EPS (Rs.) | -0.28 | -0.18 | -0.08 | -0.14 | -0.24 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -6.52 | -6.24 | -6.05 | -5.97 | -5.83 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -6.52 | -6.24 | -6.05 | -5.97 | -5.83 |
| PBDIT / Share (Rs.) | -0.28 | -0.18 | -0.08 | -0.14 | -0.24 |
| PBIT / Share (Rs.) | -0.28 | -0.18 | -0.08 | -0.14 | -0.24 |
| PBT / Share (Rs.) | -0.28 | -0.18 | -0.08 | -0.14 | -0.24 |
| Net Profit / Share (Rs.) | -0.28 | -0.18 | -0.08 | -0.14 | -0.24 |
| Return on Capital Employeed (%) | -170.80 | -853.17 | 342.31 | -1091.55 | 1173.56 |
| Return On Assets (%) | -148.88 | -203.41 | -56.42 | -96.16 | -164.79 |
| Long Term Debt / Equity (X) | -1.03 | -1.00 | -0.99 | -1.00 | -0.99 |
| Total Debt / Equity (X) | -1.03 | -1.00 | -0.99 | -1.00 | -0.99 |
| Current Ratio (X) | 4.36 | 0.06 | 0.36 | 0.46 | 0.37 |
| Quick Ratio (X) | 4.36 | 0.06 | 0.36 | 0.46 | 0.37 |
| Enterprise Value (Cr.) | 14.36 | 11.41 | 11.18 | 8.12 | 8.01 |
| EV / EBITDA (X) | -69.15 | -87.07 | -186.40 | -79.12 | -45.66 |
| Price / BV (X) | -2.04 | -1.54 | -1.57 | -0.88 | -0.91 |
| EarningsYield | -0.02 | -0.01 | -0.01 | -0.02 | -0.04 |
After reviewing the key financial ratios for Garodia Chemical Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.29. This value is below the healthy minimum of 5. It has decreased from -0.18 (Mar 24) to -0.29, marking a decrease of 0.11.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.29. This value is below the healthy minimum of 5. It has decreased from -0.18 (Mar 24) to -0.29, marking a decrease of 0.11.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 3. It has decreased from -0.18 (Mar 24) to -0.28, marking a decrease of 0.10.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -6.52. It has decreased from -6.24 (Mar 24) to -6.52, marking a decrease of 0.28.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -6.52. It has decreased from -6.24 (Mar 24) to -6.52, marking a decrease of 0.28.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 2. It has decreased from -0.18 (Mar 24) to -0.28, marking a decrease of 0.10.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 0. It has decreased from -0.18 (Mar 24) to -0.28, marking a decrease of 0.10.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 0. It has decreased from -0.18 (Mar 24) to -0.28, marking a decrease of 0.10.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 2. It has decreased from -0.18 (Mar 24) to -0.28, marking a decrease of 0.10.
- For Return on Capital Employeed (%), as of Mar 25, the value is -170.80. This value is below the healthy minimum of 10. It has increased from -853.17 (Mar 24) to -170.80, marking an increase of 682.37.
- For Return On Assets (%), as of Mar 25, the value is -148.88. This value is below the healthy minimum of 5. It has increased from -203.41 (Mar 24) to -148.88, marking an increase of 54.53.
- For Long Term Debt / Equity (X), as of Mar 25, the value is -1.03. This value is below the healthy minimum of 0.2. It has decreased from -1.00 (Mar 24) to -1.03, marking a decrease of 0.03.
- For Total Debt / Equity (X), as of Mar 25, the value is -1.03. This value is within the healthy range. It has decreased from -1.00 (Mar 24) to -1.03, marking a decrease of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 4.36. This value exceeds the healthy maximum of 3. It has increased from 0.06 (Mar 24) to 4.36, marking an increase of 4.30.
- For Quick Ratio (X), as of Mar 25, the value is 4.36. This value exceeds the healthy maximum of 2. It has increased from 0.06 (Mar 24) to 4.36, marking an increase of 4.30.
- For Enterprise Value (Cr.), as of Mar 25, the value is 14.36. It has increased from 11.41 (Mar 24) to 14.36, marking an increase of 2.95.
- For EV / EBITDA (X), as of Mar 25, the value is -69.15. This value is below the healthy minimum of 5. It has increased from -87.07 (Mar 24) to -69.15, marking an increase of 17.92.
- For Price / BV (X), as of Mar 25, the value is -2.04. This value is below the healthy minimum of 1. It has decreased from -1.54 (Mar 24) to -2.04, marking a decrease of 0.50.
- For EarningsYield, as of Mar 25, the value is -0.02. This value is below the healthy minimum of 5. It has decreased from -0.01 (Mar 24) to -0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Garodia Chemical Ltd:
- Net Profit Margin: 0%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -170.8% (Industry Average ROCE: 15.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 8.99%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.36
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 1.6 (Industry average Stock P/E: 90.53)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -1.03
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0%